Global Liquid Biopsy Products Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Delivery：Within 72h| Full Report Selling Price |
|---|
2800.00 USD |
4200.00 USD |
5600.00 USD |
| Buy NowContact Us |
| Competitor Data Selling Price |
|---|
900.00 USD |
1350.00 USD |
1800.00 USD |
| Buy NowContact Us |
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Liquid Biopsy Products market size will reach 3,998.53 Million USD in 2026 and is projected to reach 17,831.60 Million USD by 2033, with a CAGR of 23.81% (2026-2033). Notably, the China Liquid Biopsy Products market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liquid biopsy products refer to medical tools and technologies designed to detect and analyze biomarkers in the form of circulating nucleic acids, proteins, or cells found in various bodily fluids such as blood, urine, or cerebrospinal fluid. These products enable non-invasive testing and monitoring of diseases, particularly cancer, by providing information on tumor mutations, genetic variations, and treatment response. Liquid biopsy products offer a less invasive alternative to traditional tissue biopsies and hold significant potential for early detection, personalized medicine, and monitoring disease progression, ultimately improving patient care and outcomes.
The major global manufacturers of Liquid Biopsy Products include Bio Rad Laboratories, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, NeoGenomics Laboraories, Sysmex Inostics, Grail, Menarini Silicon Biosystems, Cynvenio, Adaptive Biotechnologies, Biocept, Angle plc, Burning Rock Biotech Limited, Beijing Genetron Health Technology Co., Ltd, HangZhou Watson Biotech Co.,Ltd, Shanghai Kunyuan Biological Technology Co., Ltd, Predicine, Berry Genomics, Guangzhou AnchorDx Medical Co., Ltd, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liquid Biopsy Products. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liquid Biopsy Products market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liquid Biopsy Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liquid Biopsy Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liquid Biopsy Products Include:
Bio Rad Laboratories
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Grail
Menarini Silicon Biosystems
Cynvenio
Adaptive Biotechnologies
Biocept
Angle plc
Burning Rock Biotech Limited
Beijing Genetron Health Technology Co., Ltd
HangZhou Watson Biotech Co.,Ltd
Shanghai Kunyuan Biological Technology Co., Ltd
Predicine
Berry Genomics
Guangzhou AnchorDx Medical Co., Ltd
Liquid Biopsy Products Product Segment Include:
CTCs
ctDNA
Exosomes
Liquid Biopsy Products Product Application Include:
Blood Sample
Urine Sample
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liquid Biopsy Products Industry PESTEL Analysis
Chapter 3: Global Liquid Biopsy Products Industry Porter's Five Forces Analysis
Chapter 4: Global Liquid Biopsy Products Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Liquid Biopsy Products Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Liquid Biopsy Products Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Liquid Biopsy Products Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Global Liquid Biopsy Products Revenue, Sales and Market Share by Player
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Bio Rad Laboratories | XX | XX | XX | XX | XX |
| Biocartis | XX | XX | XX | XX | XX |
| Qiagen | XX | XX | XX | XX | XX |
| Guardant Health | XX | XX | XX | XX | XX |
| MDxHealth | XX | XX | XX | XX | XX |
| Pathway Genomics | XX | XX | XX | XX | XX |
| NeoGenomics Laboraories | XX | XX | XX | XX | XX |
| Sysmex Inostics | XX | XX | XX | XX | XX |
| Grail | XX | XX | XX | XX | XX |
| Menarini Silicon Biosystems | XX | XX | XX | XX | XX |
| Cynvenio | XX | XX | XX | XX | XX |
| Adaptive Biotechnologies | XX | XX | XX | XX | XX |
| Biocept | XX | XX | XX | XX | XX |
| Angle plc | XX | XX | XX | XX | XX |
| Burning Rock Biotech Limited | XX | XX | XX | XX | XX |
| Beijing Genetron Health Technology Co., Ltd | XX | XX | XX | XX | XX |
| HangZhou Watson Biotech Co.,Ltd | XX | XX | XX | XX | XX |
| Shanghai Kunyuan Biological Technology Co., Ltd | XX | XX | XX | XX | XX |
| Predicine | XX | XX | XX | XX | XX |
| Berry Genomics | XX | XX | XX | XX | XX |
| Guangzhou AnchorDx Medical Co., Ltd | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
| Sales (K Unit) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Bio Rad Laboratories | XX | XX | XX | XX | XX |
| Biocartis | XX | XX | XX | XX | XX |
| Qiagen | XX | XX | XX | XX | XX |
| Guardant Health | XX | XX | XX | XX | XX |
| MDxHealth | XX | XX | XX | XX | XX |
| Pathway Genomics | XX | XX | XX | XX | XX |
| NeoGenomics Laboraories | XX | XX | XX | XX | XX |
| Sysmex Inostics | XX | XX | XX | XX | XX |
| Grail | XX | XX | XX | XX | XX |
| Menarini Silicon Biosystems | XX | XX | XX | XX | XX |
| Cynvenio | XX | XX | XX | XX | XX |
| Adaptive Biotechnologies | XX | XX | XX | XX | XX |
| Biocept | XX | XX | XX | XX | XX |
| Angle plc | XX | XX | XX | XX | XX |
| Burning Rock Biotech Limited | XX | XX | XX | XX | XX |
| Beijing Genetron Health Technology Co., Ltd | XX | XX | XX | XX | XX |
| HangZhou Watson Biotech Co.,Ltd | XX | XX | XX | XX | XX |
| Shanghai Kunyuan Biological Technology Co., Ltd | XX | XX | XX | XX | XX |
| Predicine | XX | XX | XX | XX | XX |
| Berry Genomics | XX | XX | XX | XX | XX |
| Guangzhou AnchorDx Medical Co., Ltd | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
Related Report
Global Dydrogesterone Drug Competitive Landscape Professional Research Report 2026
Global Dydrogesterone Drug Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Olanzapine Competitive Landscape Professional Research Report 2026
Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Pool Library Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Pool Library Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Order Process
Contact
1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you
2. You can also directly call our customer service hotline or add customer service WeChat
Samples
1. One on one business specialist will send the complete version of the sample
2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
1. Both parties sign a report purchase contract
2. Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
1. PDF report (sent online 2-3 working days after payment)
2. WORD version report (sent online 2-3 working days after payment)
3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
